CROSS CTRY HEALTHCARE INC's ticker is CCRN and the CUSIP is 227483104. A total of 187 filers reported holding CROSS CTRY HEALTHCARE INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $693 | +65.8% | 27,960 | +77.9% | 0.03% | +43.5% |
| Q4 2022 | $418 | -100.0% | 15,717 | -86.2% | 0.02% | -88.3% |
| Q3 2022 | $3,243,000 | +60.1% | 114,301 | +17.5% | 0.20% | +28.9% |
| Q2 2022 | $2,026,000 | +39.2% | 97,241 | +44.8% | 0.15% | +60.0% |
| Q1 2022 | $1,455,000 | +407.0% | 67,161 | +397.0% | 0.10% | +150.0% |
| Q3 2021 | $287,000 | +43.5% | 13,514 | +11.7% | 0.04% | -43.3% |
| Q2 2021 | $200,000 | -83.3% | 12,100 | -85.5% | 0.07% | -79.3% |
| Q1 2017 | $1,196,000 | -3.4% | 83,285 | +5.0% | 0.32% | -8.8% |
| Q4 2016 | $1,238,000 | +228.4% | 79,330 | +147.9% | 0.35% | +224.8% |
| Q3 2016 | $377,000 | +13.9% | 31,995 | +34.7% | 0.11% | -18.7% |
| Q2 2016 | $331,000 | +19.9% | 23,757 | 0.0% | 0.13% | +30.1% |
| Q1 2016 | $276,000 | +0.7% | 23,757 | +42.3% | 0.10% | -19.5% |
| Q4 2015 | $274,000 | -84.1% | 16,694 | -90.3% | 0.13% | -72.1% |
| Q4 2013 | $1,718,000 | +474.6% | 172,098 | +247.4% | 0.46% | +433.7% |
| Q3 2013 | $299,000 | +60.8% | 49,532 | +37.3% | 0.09% | +48.3% |
| Q2 2013 | $186,000 | – | 36,088 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 305,925 | $2,671,000 | 1.43% |
| Benefit Street Partners LLC | 1,339,640 | $11,695,000 | 0.83% |
| SKYLINE ASSET MANAGEMENT LP | 956,489 | $8,350,000 | 0.74% |
| Aristotle Capital Boston, LLC | 1,001,236 | $8,741,000 | 0.64% |
| EAGLE BOSTON INVESTMENT MANAGEMENT INC | 751,859 | $6,563,000 | 0.59% |
| HEARTLAND ADVISORS INC | 768,390 | $6,708,000 | 0.45% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 904,900 | $7,900,000 | 0.36% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 854,010 | $7,456,000 | 0.18% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 89,186 | $779,000 | 0.16% |
| J. Goldman & Co LP | 229,393 | $2,003,000 | 0.14% |